{"pmid":32396261,"title":"Safety during crisis: Rapid on-site evaluation at the time of COVID-19 pandemic.","text":["Safety during crisis: Rapid on-site evaluation at the time of COVID-19 pandemic.","The COVID-19 pandemic is posing a worldwide challenge to control and contain. SARS-CoV-2 is a highly infectious virus. Health care providers at the front lines are at high risk of getting the infection and the risk applies also to laboratory personnel as they deal with specimens that might be contaminated with infectious materiel. Cytopathology teams specifically are at high risk of dealing with contaminated material because of patients encounter during fine-needle aspiration biopsies or Rapid On-Site Evaluation (ROSE) for adequacy. In our article, we discuss alternative safer staining methods to the widely used Diff-Quick stain that can be utilized for ROSE to decrease the risk of viral exposure during the current COVID-19 pandemic.","Diagn Cytopathol","Asiry, Saeed","Fatyan, Alaaeddin","Matloob, Ammar","Khader, Samer N","32396261"],"abstract":["The COVID-19 pandemic is posing a worldwide challenge to control and contain. SARS-CoV-2 is a highly infectious virus. Health care providers at the front lines are at high risk of getting the infection and the risk applies also to laboratory personnel as they deal with specimens that might be contaminated with infectious materiel. Cytopathology teams specifically are at high risk of dealing with contaminated material because of patients encounter during fine-needle aspiration biopsies or Rapid On-Site Evaluation (ROSE) for adequacy. In our article, we discuss alternative safer staining methods to the widely used Diff-Quick stain that can be utilized for ROSE to decrease the risk of viral exposure during the current COVID-19 pandemic."],"journal":"Diagn Cytopathol","authors":["Asiry, Saeed","Fatyan, Alaaeddin","Matloob, Ammar","Khader, Samer N"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32396261","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1002/dc.24453","keywords":["covid-19","rose","fine-needle aspiration","safety","virus"],"topics":["Prevention"],"weight":1,"_version_":1666627827898777600,"score":9.490897,"similar":[{"pmid":32312717,"title":"Cytology in the time of coronavirus disease (covid-19): an Italian perspective.","text":["Cytology in the time of coronavirus disease (covid-19): an Italian perspective.","INTRODUCTION: The coronavirus disease 2019 (covid-19) is changing the way we practice pathology, including fine needle aspiration (FNA) diagnostics. Although recommendations have been issued to prioritise patients at high oncological risk, postponing those with unsuspicious presentations, real world data have not been reported yet. METHODS: The percentages of the cytological sample types processed at the University of Naples Federico II, during the first 3 weeks of Italian national lockdown were compared with those of the same period in 2019. RESULTS: During the emergency, the percentage of cytology samples reported as malignant increased (p<0.001), reflecting higher percentages of breast (p=0.002) and lymph nodes FNAs (p=0.008), effusions (p<0.001) and urine (p=0.005). Conversely, thyroid FNAs (p<0.001) and Pap smears (p=0.003) were reduced. CONCLUSIONS: Even in times of covid-19 outbreak, cytological examination may be safely carried out in patients at high oncological risk, without the need to be postponed.","J Clin Pathol","Vigliar, Elena","Iaccarino, Antonino","Bruzzese, Dario","Malapelle, Umberto","Bellevicine, Claudio","Troncone, Giancarlo","32312717"],"abstract":["INTRODUCTION: The coronavirus disease 2019 (covid-19) is changing the way we practice pathology, including fine needle aspiration (FNA) diagnostics. Although recommendations have been issued to prioritise patients at high oncological risk, postponing those with unsuspicious presentations, real world data have not been reported yet. METHODS: The percentages of the cytological sample types processed at the University of Naples Federico II, during the first 3 weeks of Italian national lockdown were compared with those of the same period in 2019. RESULTS: During the emergency, the percentage of cytology samples reported as malignant increased (p<0.001), reflecting higher percentages of breast (p=0.002) and lymph nodes FNAs (p=0.008), effusions (p<0.001) and urine (p=0.005). Conversely, thyroid FNAs (p<0.001) and Pap smears (p=0.003) were reduced. CONCLUSIONS: Even in times of covid-19 outbreak, cytological examination may be safely carried out in patients at high oncological risk, without the need to be postponed."],"journal":"J Clin Pathol","authors":["Vigliar, Elena","Iaccarino, Antonino","Bruzzese, Dario","Malapelle, Umberto","Bellevicine, Claudio","Troncone, Giancarlo"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32312717","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1136/jclinpath-2020-206614","keywords":["cytological techniques","health services","infection control","medical oncology","safety"],"locations":["Italian","Italian"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1666138493468803074,"score":147.77481},{"pmid":32475066,"title":"Two Detailed Plaque Assay Protocols for the Quantification of Infectious SARS-CoV-2.","text":["Two Detailed Plaque Assay Protocols for the Quantification of Infectious SARS-CoV-2.","Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been identified as the causal agent of COronaVIrus Disease-19 (COVID-19), an atypical pneumonia-like syndrome that emerged in December 2019. While SARS-CoV-2 titers can be measured by detection of viral nucleic acid, this method is unable to quantitate infectious virions. Measurement of infectious SARS-CoV-2 can be achieved by tissue culture infectious dose-50 (TCID50 ), which detects the presence or absence of cytopathic effect in cells infected with serial dilutions of a virus specimen. However, this method only provides a qualitative infectious virus titer. Plaque assays are a quantitative method of measuring infectious SARS-CoV-2 by quantifying the plaques formed in cell culture upon infection with serial dilutions of a virus specimen. As such, plaque assays remain the gold standard in quantifying concentrations of replication-competent lytic virions. Here, we describe two detailed plaque assay protocols to quantify infectious SARS-CoV-2 using different overlay and staining methods. Both methods have several advantages and disadvantages, which can be considered when choosing the procedure best suited for each laboratory. These assays can be used for several research purposes, including titration of virus stocks produced from infected cell supernatant and, with further optimization, quantification of SARS-CoV-2 in specimens collected from infected animals. (c) 2019 The Authors. Basic Protocol: SARS-CoV-2 plaque assay using a solid double overlay method Alternate Protocol: SARS-CoV-2 plaque assay using a liquid overlay and fixation-staining method.","Curr Protoc Microbiol","Mendoza, Emelissa J","Manguiat, Kathy","Wood, Heidi","Drebot, Michael","32475066"],"abstract":["Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been identified as the causal agent of COronaVIrus Disease-19 (COVID-19), an atypical pneumonia-like syndrome that emerged in December 2019. While SARS-CoV-2 titers can be measured by detection of viral nucleic acid, this method is unable to quantitate infectious virions. Measurement of infectious SARS-CoV-2 can be achieved by tissue culture infectious dose-50 (TCID50 ), which detects the presence or absence of cytopathic effect in cells infected with serial dilutions of a virus specimen. However, this method only provides a qualitative infectious virus titer. Plaque assays are a quantitative method of measuring infectious SARS-CoV-2 by quantifying the plaques formed in cell culture upon infection with serial dilutions of a virus specimen. As such, plaque assays remain the gold standard in quantifying concentrations of replication-competent lytic virions. Here, we describe two detailed plaque assay protocols to quantify infectious SARS-CoV-2 using different overlay and staining methods. Both methods have several advantages and disadvantages, which can be considered when choosing the procedure best suited for each laboratory. These assays can be used for several research purposes, including titration of virus stocks produced from infected cell supernatant and, with further optimization, quantification of SARS-CoV-2 in specimens collected from infected animals. (c) 2019 The Authors. Basic Protocol: SARS-CoV-2 plaque assay using a solid double overlay method Alternate Protocol: SARS-CoV-2 plaque assay using a liquid overlay and fixation-staining method."],"journal":"Curr Protoc Microbiol","authors":["Mendoza, Emelissa J","Manguiat, Kathy","Wood, Heidi","Drebot, Michael"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32475066","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/cpmc.105","keywords":["covid-19","covid19","sars-cov-2","plaque assay","virus quantification"],"topics":["Diagnosis"],"weight":1,"_version_":1668341932634406912,"score":140.8598},{"pmid":32298146,"title":"Hospital Preparedness for COVID-19: A Practical Guide from a Critical Care Perspective.","text":["Hospital Preparedness for COVID-19: A Practical Guide from a Critical Care Perspective.","In response to the estimated potential impact of COVID-19 on New York City hospitals, our institution prepared for an influx of critically ill patients. Multiple areas of surge planning progressed simultaneously focused on infection control, clinical operational challenges, intensive care unit surge capacity, staffing, ethics and maintenance of staff wellness. Protocols developed focused on clinical decisions around intubation, the use of high-flow oxygen, infectious disease consultation and cardiac arrest. Mechanisms to increase bed capacity as well as increase efficiency in intensive care units by outsourcing procedures were implemented. Novel uses of technology to minimize staff exposure to COVID-19, as well as to facilitate family engagement and end of life discussions were encouraged. Education and communication remained key in attempting to standardize care, stay apprized on emerging data as well as to review seminal literature on respiratory failure. Challenges were encountered, and overcome through interdisciplinary collaboration and iterative surge planning as intensive care unit admissions rose. Support was provided for both clinical and nonclinical staff affected by the profound impact COVID-19 had on our city. We describe in granular detail, the procedures and processes developed during a one month period while surge planning was ongoing and the need for intensive care unit capacity rose exponentially. The approaches described provide a potential roadmap for centers that must rapidly adapt to the tremendous challenge introduced by this and potential future pandemics. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/).","Am J Respir Crit Care Med","Griffin, Kelly M","Karas, Maria G","Ivascu, Natalia S","Lief, Lindsay","32298146"],"abstract":["In response to the estimated potential impact of COVID-19 on New York City hospitals, our institution prepared for an influx of critically ill patients. Multiple areas of surge planning progressed simultaneously focused on infection control, clinical operational challenges, intensive care unit surge capacity, staffing, ethics and maintenance of staff wellness. Protocols developed focused on clinical decisions around intubation, the use of high-flow oxygen, infectious disease consultation and cardiac arrest. Mechanisms to increase bed capacity as well as increase efficiency in intensive care units by outsourcing procedures were implemented. Novel uses of technology to minimize staff exposure to COVID-19, as well as to facilitate family engagement and end of life discussions were encouraged. Education and communication remained key in attempting to standardize care, stay apprized on emerging data as well as to review seminal literature on respiratory failure. Challenges were encountered, and overcome through interdisciplinary collaboration and iterative surge planning as intensive care unit admissions rose. Support was provided for both clinical and nonclinical staff affected by the profound impact COVID-19 had on our city. We describe in granular detail, the procedures and processes developed during a one month period while surge planning was ongoing and the need for intensive care unit capacity rose exponentially. The approaches described provide a potential roadmap for centers that must rapidly adapt to the tremendous challenge introduced by this and potential future pandemics. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/)."],"journal":"Am J Respir Crit Care Med","authors":["Griffin, Kelly M","Karas, Maria G","Ivascu, Natalia S","Lief, Lindsay"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32298146","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1164/rccm.202004-1037CP","keywords":["sars virus","intensive care units","pandemics"],"locations":["New York"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666138493319905280,"score":131.19992},{"pmid":32259373,"title":"Cytologic and histologic samples from patients infected by the novel coronavirus 2019 SARS-CoV-2: An italian institutional experience focusing on biosafety procedures.","text":["Cytologic and histologic samples from patients infected by the novel coronavirus 2019 SARS-CoV-2: An italian institutional experience focusing on biosafety procedures.","The 2019 coronavirus pandemic, which started in Wuhan, China, spread around the globe with dramatic and lethal effects. From the initial Chinese epicenter, the European diaspora taxed the resources of several countries and especially those of Italy, which was forced into a complete social and economic shutdown. Infection by droplets contaminating hands and surfaces represents the main vehicle of diffusion of the virus. The common and strong efforts to contain the pandemic have relevant effects on the management of samples from histopathology laboratories. The current commentary reports and focuses on the protocols and guidelines in use at a large tertiary Italian hospital that accordingly are proposed for adoption in Italian laboratories as a potential model for national guidelines for the coronavirus emergency.","Cancer Cytopathol","Rossi, Esther Diana","Fadda, Guido","Mule, Antonino","Zannoni, Gian Franco","Rindi, Guido","32259373"],"abstract":["The 2019 coronavirus pandemic, which started in Wuhan, China, spread around the globe with dramatic and lethal effects. From the initial Chinese epicenter, the European diaspora taxed the resources of several countries and especially those of Italy, which was forced into a complete social and economic shutdown. Infection by droplets contaminating hands and surfaces represents the main vehicle of diffusion of the virus. The common and strong efforts to contain the pandemic have relevant effects on the management of samples from histopathology laboratories. The current commentary reports and focuses on the protocols and guidelines in use at a large tertiary Italian hospital that accordingly are proposed for adoption in Italian laboratories as a potential model for national guidelines for the coronavirus emergency."],"journal":"Cancer Cytopathol","authors":["Rossi, Esther Diana","Fadda, Guido","Mule, Antonino","Zannoni, Gian Franco","Rindi, Guido"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32259373","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1002/cncy.22281","keywords":["biosafety guidelines","coronavirus","cytology","fine-needle aspiration","histology","personalized medicine"],"locations":["Wuhan","China","Chinese","Italy","Italian","Italian","italian"],"countries":["Italy","China"],"countries_codes":["ITA|Italy","CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138493132210176,"score":122.48169},{"pmid":32279934,"pmcid":"PMC7146651","title":"Anesthesia Management and Perioperative Infection Control in Patients With the Novel Coronavirus.","text":["Anesthesia Management and Perioperative Infection Control in Patients With the Novel Coronavirus.","Anesthesiologists have a high risk of infection with COVID-19 during perioperative care and as first responders to airway emergencies. The potential of becoming infected can be reduced by a systematic and integrated approach that assesses infection risk. The latter leads to an acceptable choice of materials and techniques for personal protection and prevention of cross-contamination to other patients and staff. The authors have presented a protocolized approach that uses diagnostic criteria to clearly define benchmarks from the medical history along with clinical symptoms and laboratory tests. Patients can then be rapidly assigned into 1 of 3 risk categories that direct the choice of protective materials and/or techniques. Each hospital can adapt this approach to develop a system that fits its individual resources. Educating medical staff about the proper use of high-risk areas for containment serves to protect staff and patients.","J Cardiothorac Vasc Anesth","Li, Weixia","Huang, Jiapeng","Guo, Xiangyang","Zhao, Jing","Mandell, M Susan","32279934"],"abstract":["Anesthesiologists have a high risk of infection with COVID-19 during perioperative care and as first responders to airway emergencies. The potential of becoming infected can be reduced by a systematic and integrated approach that assesses infection risk. The latter leads to an acceptable choice of materials and techniques for personal protection and prevention of cross-contamination to other patients and staff. The authors have presented a protocolized approach that uses diagnostic criteria to clearly define benchmarks from the medical history along with clinical symptoms and laboratory tests. Patients can then be rapidly assigned into 1 of 3 risk categories that direct the choice of protective materials and/or techniques. Each hospital can adapt this approach to develop a system that fits its individual resources. Educating medical staff about the proper use of high-risk areas for containment serves to protect staff and patients."],"journal":"J Cardiothorac Vasc Anesth","authors":["Li, Weixia","Huang, Jiapeng","Guo, Xiangyang","Zhao, Jing","Mandell, M Susan"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32279934","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1053/j.jvca.2020.03.035","keywords":["covid-19","anesthesia","infection","safety"],"topics":["Prevention"],"weight":1,"_version_":1666138491526840321,"score":121.88805}]}